Check out our latest industry white papers. Browse now!
Sales & Support: +1 800 762 3361
Member Resources

KOFU, JAPAN--April 19, 2021--Researched by Industrial Info Resources (Sugar Land, Texas)--South Korea's largest pharmaceutical companies are focusing on producing biosimilar products. Samsung Biologics, Celltrion and Prestige Biologics are expanding their production facilities with $1.66 billion worth of projects, and other mid-sized companies are expected to focus on developing and producing biosimilars with an eye on both domestic and export markets.

Login or Register for Instant Access

Subscribe Now!

(All Fields Required)

IIR Logo Globe

Site-wide Scheduled Maintenance for April 12, 2025, between 9 A.M. - 9 P.M. CST. During this time, all services will be unavailable periodically throughout the scheduled maintenance window.

×
×

Contact Us

For More Info!